RETROMOX 457 DRY SYRUP

Amoxycillin, a semisynthetic penicillin, acts by inhibiting bacterial cell wall synthesis, leading to the destruction of the bacterial cell. However, many bacteria produce β-lactamase enzymes that can render Amoxycillin inactive. To overcome this resistance, Clavulanic Acid, a potent β-lactamase inhibitor, is included in the formulation. It protects Amoxycillin from enzymatic degradation, thereby extending its antibacterial spectrum and ensuring reliable treatment outcomes even against resistant bacterial strains.

RETROMOX 457 Dry Syrup is indicated for the treatment of respiratory tract infections (such as tonsillitis, pharyngitis, and sinusitis), otitis media, urinary tract infections, skin and soft tissue infections, and lower respiratory tract infections including bronchitis and pneumonia. The formulation offers rapid relief from fever, inflammation, and discomfort, promoting faster recovery and restoring well-being. Its pleasant taste and easy-to-reconstitute powder form make it especially suitable for children, ensuring accurate dosing and better acceptance.

Manufactured under strict quality assurance and safety guidelines, RETROMOX 457 Dry Syrup offers superior stability, excellent absorption, and high therapeutic efficacy. It is well tolerated and safe for pediatric use under medical supervision. By combining the proven power of Amoxycillin with the resistance-fighting action of Clavulanic Acid, RETROMOX 457 Dry Syrup delivers comprehensive antibacterial protection — ensuring effective infection control, faster healing, and confident care for children.